home_healthy_pic6
About us

IP CURE B

IP-cure-B is a five-year project started in January 2020, coordinated by INSERM in France.

Our collaborative network brings together 13 complementary partners, including 10 research institutions, 1 pharmaceutical company, 1 patient association and 1 private company from 9 different countries (including 8 European member states).

View More
IP Cure B

Our Project

Context

Hepatitis B virus (HBV) is a major global public health threat with over 257 million people worldwide.

Strategy

Stimulating innate signaling and inhibiting viral replication in infected hepatocytes.

Objectives

Perform a proof of concept clinical trial to evaluate novel immune modulators and their combination to boost…

Expected Results

Improve the functional cure rate in « CHB » Chronic Hepatitis B and provide opportunities for finite duration curing therapies…

What We Do

IP-Cure-B is here for you!

user

For Patients

View More
newspaper

Events

View More
Video

Hear from the principal investigators

Maria Buti
Susanna Tan
Carlo Ferrari
Fabien Zoulim
Massimo Levrero
Pietro Lampertico
Hélène Strick-Marchand
Marko Korenjak
News

Project News & Events